Cullinan Therapeutics CEO Nadim Ahmed's 2023 pay rises 3% to $4M

Cullinan Therapeutics reports 2023 executive compensation

By ExecPay News

Published: May 16, 2024

Cullinan Therapeutics reported fiscal year 2023 executive compensation information on May 16, 2024.
In 2023, three executives at Cullinan Therapeutics received on average a compensation package of $2.9M, a 11% increase compared to previous year.
Average pay of disclosed executives at Cullinan Therapeutics
Nadim Ahmed, Chief Executive Officer, received $4M in total, which increased by 3% compared to 2022. 41% of Ahmed's compensation, or $1.6M, was in option awards. Ahmed also received $389K in bonus, $649K in salary, $1.2M in stock awards, as well as $122K in other compensation.
Jeffrey Jones, Chief Medical Officer, received a compensation package of $2.4M. 40% of the compensation package, or $961K, was in option awards.
Jeffrey Trigilio, Chief Financial Officer, earned $2.2M in 2023, a 15% increase compared to previous year.

Related executives

Nadim Ahmed

Cullinan Therapeutics

Chief Executive Officer

Jeffrey Jones

Cullinan Therapeutics

Chief Medical Officer

Jeffrey Trigilio

Cullinan Therapeutics

Chief Financial Officer

You may also like

Source: SEC filing on May 16, 2024.